NO20005079L - Fremgangsmåte for sterilisering av nativt kollagen i flytende medium, resulterende nativt-kollagenblandinger inneholdende samme og anvendelser - Google Patents

Fremgangsmåte for sterilisering av nativt kollagen i flytende medium, resulterende nativt-kollagenblandinger inneholdende samme og anvendelser

Info

Publication number
NO20005079L
NO20005079L NO20005079A NO20005079A NO20005079L NO 20005079 L NO20005079 L NO 20005079L NO 20005079 A NO20005079 A NO 20005079A NO 20005079 A NO20005079 A NO 20005079A NO 20005079 L NO20005079 L NO 20005079L
Authority
NO
Norway
Prior art keywords
collagen
native
liquid medium
sterilizing
same
Prior art date
Application number
NO20005079A
Other languages
English (en)
Other versions
NO20005079D0 (no
Inventor
Hamza Mansour
Original Assignee
Octapharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Octapharma Ag filed Critical Octapharma Ag
Publication of NO20005079D0 publication Critical patent/NO20005079D0/no
Publication of NO20005079L publication Critical patent/NO20005079L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/32—Proteins, polypeptides; Degradation products or derivatives thereof, e.g. albumin, collagen, fibrin, gelatin
    • A61L15/325—Collagen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
    • A61L2/0017—Filtration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0082—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using chemical substances
    • A61L2/0088—Liquid substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0028—Polypeptides; Proteins; Degradation products thereof
    • A61L26/0033—Collagen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0052—Mixtures of macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/043—Proteins; Polypeptides; Degradation products thereof
    • A61L31/044—Collagen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Surgery (AREA)
  • Diabetes (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Materials For Medical Uses (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Distillation Of Fermentation Liquor, Processing Of Alcohols, Vinegar And Beer (AREA)
NO20005079A 1998-04-10 2000-10-09 Fremgangsmåte for sterilisering av nativt kollagen i flytende medium, resulterende nativt-kollagenblandinger inneholdende samme og anvendelser NO20005079L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9804531A FR2777284B1 (fr) 1998-04-10 1998-04-10 Procede de sterilisation d'un collagene natif en milieu liquide, collagene natif sterile obtenu, compositions le contenant et applications
PCT/FR1999/000814 WO1999052946A1 (fr) 1998-04-10 1999-04-09 Procede de sterilisation d'un collagene natif en milieu liquide, collagene natif sterile obtenu, compositions le contenant et applications

Publications (2)

Publication Number Publication Date
NO20005079D0 NO20005079D0 (no) 2000-10-09
NO20005079L true NO20005079L (no) 2000-12-08

Family

ID=9525129

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20005079A NO20005079L (no) 1998-04-10 2000-10-09 Fremgangsmåte for sterilisering av nativt kollagen i flytende medium, resulterende nativt-kollagenblandinger inneholdende samme og anvendelser

Country Status (20)

Country Link
EP (1) EP1068240B1 (no)
JP (1) JP2002511489A (no)
KR (1) KR20010042539A (no)
CN (1) CN1304416A (no)
AT (1) ATE229982T1 (no)
AU (1) AU3151499A (no)
BR (1) BR9909566A (no)
CA (1) CA2327882A1 (no)
DE (1) DE69904578T2 (no)
EE (1) EE200000592A (no)
FR (1) FR2777284B1 (no)
HU (1) HUP0102575A2 (no)
ID (1) ID26038A (no)
IL (1) IL138562A0 (no)
NO (1) NO20005079L (no)
PL (1) PL343523A1 (no)
RU (1) RU2188206C2 (no)
WO (1) WO1999052946A1 (no)
YU (1) YU61100A (no)
ZA (1) ZA200005497B (no)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030017528A1 (en) 1998-11-20 2003-01-23 Ruoping Chen Human orphan G protein-coupled receptors
US7816492B2 (en) 1998-11-20 2010-10-19 Arena Pharmaceuticals, Inc. Human G protein-coupled receptors
USRE42190E1 (en) 1998-11-20 2011-03-01 Arena Pharmaceuticals, Inc. Method of identifying a compound for inhibiting or stimulating human G protein-coupled receptors
AT411326B (de) * 2000-06-20 2003-12-29 Biering Wolfgang Hämostatische collagen-pellets
JP4705359B2 (ja) * 2004-10-20 2011-06-22 新田ゼラチン株式会社 鳥類由来コラーゲンを用いてなる化粧料組成物
DE102005017845A1 (de) 2005-04-18 2006-10-19 Lohmann & Rauscher Gmbh & Co. Kg Autosterile, antiseptische Kollagenzubereitungen, ihre Verwendung und Verfahren zu ihrer Herstellung
CN101332316B (zh) * 2008-07-22 2012-12-26 广东冠昊生物科技股份有限公司 生物型鼻梁植入体
US20080102095A1 (en) * 2006-10-31 2008-05-01 Kent Young Acidic processes to prepare antimicrobial contact lenses
KR101629517B1 (ko) 2007-06-01 2016-06-13 교와 핫꼬 바이오 가부시키가이샤 경구 조성물
RS56367B1 (sr) 2011-05-24 2017-12-29 Takeda As Umotani kolagenski nosač
WO2013174874A1 (en) * 2012-05-24 2013-11-28 Takeda Nycomed As Apparatus and process for providing a coiled collagen carrier
US10485715B2 (en) 2012-05-24 2019-11-26 Takeda As Packaging for form-stable coiled collagen carrier
CN102846536B (zh) * 2012-09-26 2014-03-26 关节动力安达（天津）生物科技有限公司 一种含有i型胶原蛋白的精华液
RU2597085C2 (ru) * 2013-11-07 2016-09-10 Федеральное государственное бюджетное учреждение науки Институт биологии моря им. А.В. Жирмунского Дальневосточного отделения Российской академии наук (ИБМ ДВО РАН) Имплантируемый матриксный материал для регенеративной медицины и способ его получения (варианты)
EP3786175A4 (en) * 2018-04-27 2022-03-23 Toppan Printing Co., Ltd. COMPOSITION CONTAINING EXTRACELLULAR MATRIX, TEMPORARY SCAFFOLD FOR FORMING THREE-DIMENSIONAL TISSUE, THREE-DIMENSIONAL TISSUE FORMING AGENT AND METHOD FOR RECOVERING CELLS FROM THREE-DIMENSIONAL TISSUE
RU2715715C1 (ru) * 2019-03-06 2020-03-03 Общество с ограниченной ответственностью фирмы "Имтек" Стерильный прозрачный концентрированный раствор биосовместимого коллагена, способ его получения и применения
CN110354246A (zh) * 2019-07-22 2019-10-22 中肽生物科技(大连)有限公司 一种纳米级小分子复合肽养眼液的制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2462222A1 (de) * 1974-02-02 1976-05-06 Trommsdorff Fa H Loesliches, natives human-kollagen, dessen nicht-helikale peptide teilweise oder vollstaendig abgetrennt sind
US3949073A (en) * 1974-11-18 1976-04-06 The Board Of Trustees Of Leland Stanford Junior University Process for augmenting connective mammalian tissue with in situ polymerizable native collagen solution
DE3522626A1 (de) * 1985-06-25 1987-01-08 Merz & Co Gmbh & Co Loeslicher kollagen-schwamm
FR2586703B1 (fr) * 1985-09-02 1989-12-01 Merieux Inst Procede d'extraction de collagenes placentaires, collagenes obtenus notamment sous forme de gels ou de solutions et leurs applications
IT1181737B (it) * 1985-11-26 1987-09-30 Pierfrancesco Morganti Supproto di collagene biologicamente attivo per uso cosmetico e farmaceutico e metodo per prepararlo
FR2715309B1 (fr) * 1994-01-24 1996-08-02 Imedex Composition adhésive, à usage chirurgical, à base de collagène modifié par coupure oxydative et non réticulé.
CA2146090C (en) * 1994-05-10 1998-11-24 Mark E. Mitchell Apparatus and method of mixing materials in a sterile environment
US5670369A (en) * 1996-06-25 1997-09-23 Ranpak Corporation Method for the production of soluble collagen

Also Published As

Publication number Publication date
FR2777284A1 (fr) 1999-10-15
FR2777284B1 (fr) 2000-05-26
PL343523A1 (en) 2001-08-27
ATE229982T1 (de) 2003-01-15
HUP0102575A2 (hu) 2001-11-28
EP1068240A1 (fr) 2001-01-17
JP2002511489A (ja) 2002-04-16
KR20010042539A (ko) 2001-05-25
EP1068240B1 (fr) 2002-12-18
YU61100A (sh) 2003-10-31
RU2188206C2 (ru) 2002-08-27
NO20005079D0 (no) 2000-10-09
ID26038A (id) 2000-11-16
BR9909566A (pt) 2000-12-26
EE200000592A (et) 2002-04-15
AU3151499A (en) 1999-11-01
DE69904578D1 (de) 2003-01-30
ZA200005497B (en) 2001-04-24
DE69904578T2 (de) 2003-11-20
CA2327882A1 (en) 1999-10-21
WO1999052946A1 (fr) 1999-10-21
CN1304416A (zh) 2001-07-18
IL138562A0 (en) 2001-10-31

Similar Documents

Publication Publication Date Title
NO20005079L (no) Fremgangsmåte for sterilisering av nativt kollagen i flytende medium, resulterende nativt-kollagenblandinger inneholdende samme og anvendelser
IS6817A (is) Dauðhreinsun lyfja
CA2146938A1 (en) Method of Controlling Structure Stability of Collagen Fibers Produced from Solutions or Dispersions Treated with Sodium Hydroxide for Infectious Agent Deactivation
ES2032121T3 (es) Particulas de emulsion gelificadas y composiciones que las contienen.
DK0760651T3 (da) Farmaceutiske præparater stammende fra mikroemulsion-baserede geler, fremgangsmåde til fremstilling deraf samt nye mikroemulsion-baserede geler
WO2003077835A3 (en) Sodium dodecyl sulfate compositions for inactivating prions
ATE242960T1 (de) Vorrichtung und verfahren zur photoaktivierung
BR9707888A (pt) Meio de conservação e/ou de congelamento de material biológico, composição e processo de armazenagem de material biológico
ATE279112T1 (de) Verwendung von mikrobiziden und spermiziden zusammensetzungen zur inaktivierung von nicht- umhüllten viren
ES2139740T3 (es) Cola de fibrina de dos componentes.
WO1999049881A3 (de) Verwendung von hsp70 protein
AU2003285327A1 (en) Cosmetic dressings containing a waxy component, a film-forming agent and a gel-forming substance
ATE406920T1 (de) Sterilisiersystem
ES2058117T3 (es) Composicion esterilizante liquida.
ATE292382T1 (de) Zur inaktivierung von infektiösen proteinen behandelte zusammensetzungen
DE69120287D1 (en) Aminosulfonylharnstoff-acat-inhibitoren
AU2623895A (en) Dialysis fluid containing peptides obtained from casein as osmotic agents and bicarbonate ions as buffering agents
ATE305295T1 (de) Vorrichtung zur freigabe von stoffen
NO995838L (no) Nye heteroetynylenforbindelser og farmasoeytiske og kosmetiske preparater inneholdende de samme
BR0014058A (pt) Produto sólido, composição, solução aquosa de 4,4-dimetil-5a-colesta-8,14,24-triene-3(beta) -ol, e, dispositivo tendo uma concavidade
Yamamoto et al. Inhibitory Effect of Lead on the Release of Tissue Plasminogen Activator from Human Vascular Endothelial Cells in Culture (Proceedings of the 18th Symposium on Toxicology, and Environmental Health)
DE69808663D1 (de) Neomycin/disaccharid wässerige lösung zur behandlung von enteroclysis bei hepatischer enzephalopathie
DE3761283D1 (de) Zusammensetzungen zur desinfektion und zur sterilisation.
Tsuji et al. An Application of Fuzzy System to Orthodontic Diagnosis in Orthosurgical Case
Kaji et al. Remodeling of Vascular Endothelial Glycocalyx by Basic Fibroblast Growth Factor (Proceedings of the 23rd Symposium on Toxicology and Environmental Health)

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application